ANTONIO JOSÉ
CARUZ ARCOS
CATEDRATICO DE UNIVERSIDAD
![Foto de José](/img/nophoto.png)
José
Benito
Publicaciones en las que colabora con José Benito (8)
2019
-
A Knockout IFNL4 Variant Is Associated with Protection from Sexually Transmitted HIV-1 Infection
Journal of Infectious Diseases, Vol. 219, Núm. 5, pp. 772-776
2013
-
A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients
Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 4, pp. 915-921
2012
-
Differences in virological response to peginterferon-a plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1b
Journal of Acquired Immune Deficiency Syndromes, Vol. 60, Núm. 2, pp. 117-123
-
Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load
Journal of Hepatology, Vol. 56, Núm. 4, pp. 788-794
2011
-
Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype
HIV Medicine, Vol. 12, Núm. 8, pp. 487-493
-
Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV-hepatitis C virus-coinfected patients with prior nonresponse or relapse
AIDS, Vol. 25, Núm. 8, pp. 1131-1133
-
Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy
Journal of Infectious Diseases, Vol. 203, Núm. 11, pp. 1629-1636
2010
-
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV
Clinical Infectious Diseases, Vol. 51, Núm. 10, pp. 1209-1216